A Review on the Effect of Tumor Necrosis Factor Inhibitors on Structural Progression in Early Axial Spondyloarthritis Using Magnetic Resonance Imaging.

Li, Ko-Jen; Jois, Ramesh; Lichauco, Juan Javier; Santos Estrella, Paul; Llamado, Lyndon John; Thorat, Amit Vilas; Mahgoub, Ehab

Li, Ko-Jen; Jois, Ramesh; Lichauco, Juan Javier; Santos Estrella, Paul; Llamado, Lyndon John; Thorat, Amit Vilas; Mahgoub, Ehab.

Afiliação

Li KJ; National Taiwan University Hospital, Taipei, Taiwan. dtmed170@gmail.com.
Jois R; Fortis Hospital, Bangalore, India.
Lichauco JJ; St. Luke's Medical Center, Quezon City, Philippines.
Santos Estrella P; Pfizer, Makati City, Philippines.
Llamado LJ; Pfizer, Makati City, Philippines.
Thorat AV; Pfizer Ltd, Mumbai, India.
Mahgoub E; Pfizer, Collegeville, PA, USA.

Rheumatol Ther ; 6(2): 139-163, 2019 Jun.

Article em En | MEDLINE | ID: mdl-30788780

Palavras-chave

Adalimumab; Axial spondyloarthritis; Certolizumab; Etanercept; Golimumab; Infliximab; Lesions; Magnetic resonance imaging; Tumor necrosis factor inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Revista: Rheumatol Ther Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google